Wedgewood Partners released its fourth-quarter 2025 investor letter, anticipating increased market volatility. The Wedgewood Composite returned -1.8% in Q4 compared to indexes. Poor stock selection and valuation corrections drove underperformance. Edwards Lifesciences Corporation (NYSE:EW) contributed positively to performance, with a favorable outlook for future growth. Edwards Lifesciences Corporation (NYSE:EW) stock closed at $84.35 per share on January 16, 2026, with a market cap of $49.522 billion. Hedge funds hold Edwards Lifesciences Corporation (NYSE:EW) in 64 portfolios, but some believe AI stocks offer greater potential.

Read more at Yahoo Finance: Does Edwards Lifesciences (EW) Have Strong Double-Digit Earnings Potential?